Co-Encapsulation of Doxorubicin With Galactoxyloglucan Nanoparticles for Intracellular Tumor-Targeted Delivery in Murine Ascites and Solid Tumors

Doxorubicin (Dox) treatment is limited by severe toxicity and frequent episodes of treatment failure. To minimize adverse events and improve drug delivery efficiently and specifically in cancer cells, encapsulation of Dox with naturally obtained galactoxyloglucan polysaccharide (PST001), isolated fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Manu M., Aravind, S.R., George, Suraj K., Pillai, Raveendran K., Mini, S., Sreelekha, T.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225659/
https://www.ncbi.nlm.nih.gov/pubmed/25389448
http://dx.doi.org/10.1016/j.tranon.2014.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225659/
https://www.ncbi.nlm.nih.gov/pubmed/25389448
http://dx.doi.org/10.1016/j.tranon.2014.07.003

Ejemplares similares